Bristol Myers Squibb Receives European Commission Approval for Opdivo + Chemotherapy for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma ... Biotech Investing
INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of APPH, BMY, EAR, HYZN Investors, Lead Plaintiff Deadlines Set Biotech Investing
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians to be Trained Biotech Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, EAR, HYZN and SAVA Biotech Investing
Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia Biotech Investing
Naturally Splendid Container of NATERA Plant Based Foods Arrives With Additional Plant-Based Offerings Biotech Investing
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, HNST, HYZN, SAM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Biotech Investing
